VimRx, Columbia University deal

By WIR Staff | Dec 8, 2008 | 8:00 AM GMT

VMRX acquired an exclusive worldwide license to Factor IXa from Columbia. In preclinical studies, the factor

Read the full 162 word article

How to gain access

Continue reading with a
two-week free trial.